ArticleBioinformatics (Oxford, England)2025
TransFactor-prediction of pro-viral SARS-CoV-2 host factors using a protein language model.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Protein Language Models in Virology: A Review of Advances and Applications.Methods in molecular biology (Clifton, N.J.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
motivationRecent pandemics have revealed significant gaps in our understanding of viral pathogenesis, exposing an urgent need for methods to identify and prioritize key host proteins (host factors) as potential targets for antiviral treatments. De novo generation of experimental datasets is limited by their heterogeneity, and for looming future pandemics, may not be feasible due to limitations of experimental approaches.
resultsHere, we present TransFactor, a computational framework for predicting and prioritizing candidate host factors using only protein sequence data. It leverages the pre-trained ESM-2 protein language model, fine-tuned on a limited set of experimentally determined host factors aggregated from 33 independent SARS-CoV-2 studies. TransFactor outperforms machine and deep learning baselines and its predictions align with Gene Ontology enrichments of known host factors, but also provide interpretability through a computational alanine scan, enabling the identification of pro-viral protein domains such as COMM, PX, and RRM, that may be used to direct experimental investigations of virus biology and guide rational design of antiviral therapies. Our findings demonstrate the potential of transformer-based models to advance host factor prediction, providing a framework extendable to orthogonal input modalities and other infectious diseases, enhancing our preparedness for current and future viral threats. AVAILABILITY AND IMPLEMENTATION: Source code is available at https://github.com/marsico-lab/TransFactor. A full reproducibility package, including code, trained models, and data, is archived on Zenodo (https://doi.org/10.5281/zenodo.16793684).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.